Showing results (1-10 of 1,100) with videos related to
Sort By:
Pageof 110
Discovery Medicine|June 30, 2012
Ewing's sarcoma: overcoming the therapeutic plateauVivek Subbiah, Razelle KurzrockTrends in Cancer|June 20, 2026
Beyond one gene, one target: Next-generation precision oncologyVivek Subbiah, Razelle KurzrockCurrent Opinion in Oncology|April 27, 2011
Phase 1 clinical trials for sarcomas: the cutting edgeVivek Subbiah, Razelle KurzrockTrends in Cancer|February 21, 2018
Challenging Standard-of-Care Paradigms in the Precision Oncology EraVivek Subbiah, Razelle KurzrockCancer Cell|August 30, 2024
Precision oncology across the ages: Impact on children, adolescents, and young adultsVivek Subbiah, Razelle KurzrockEuropean Journal of Cancer (Oxford, England : 1990)|May 9, 2026
The case for tumour-agnostic reimbursement of dual immunotherapyVivek Subbiah, Razelle KurzrockTrends in Cancer|October 3, 2020
From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision ParadigmJacob J Adashek, Vivek Subbiah, Razelle KurzrockExpert Opinion on Investigational Drugs|September 23, 2011
Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver - Will it hit the moving target?Vivek Subbiah, Laura S Angelo, Razelle KurzrockCancer|November 7, 2023
Revolutionizing cancer drug development: Harnessing the potential of basket trialsVivek Subbiah, Howard A Burris, Razelle KurzrockJCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.Pageof 110